OneMedNet Hits Data Milestone, but Liquidity and Revenue Challenges Persist

What happened

OneMedNet announced its iRWD network surpassed 90 million patient journeys and 270 million studies, with over 2,300 healthcare sites, up from 1,400+ previously. This milestone aligns with the company's stated strategic priority of expanding its data network to drive long-term value. However, the company remains in a precarious financial position, with only ~$0.1M cash and $1.6M in Bitcoin as of mid-2025, and a going-concern flag from its auditor. Revenue is still sub-scale at $155K in Q2 2025, and the company is burning cash while relying on external financing. The network growth is a positive signal for iRWD adoption, but it has yet to translate into meaningful revenue or address liquidity and Nasdaq compliance risks.

Implication

The expansion demonstrates progress in building a scalable asset, which could eventually support revenue growth if bookings accelerate. However, until the company demonstrates sustained >$1M quarterly iRWD revenue, secures adequate funding, and resolves Nasdaq compliance, the risk/reward remains unfavorable. Continued network growth is a necessary but insufficient condition for a bullish thesis.

Thesis delta

The announced network growth is a positive validation of OneMedNet's strategic pivot to iRWD, showing expanded provider reach. However, it does not alter the core thesis that the company faces severe liquidity constraints and must convert network scale into revenue. The stance remains SELL until iRWD revenue reaches meaningful levels and balance sheet risks are reduced.